Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
hyoscine butylbromide, Quantity: 20 mg
Cipla Australia Pty Ltd
Hyoscine butylbromide
Tablet, film coated
Excipient Ingredients: povidone; microcrystalline cellulose; purified water; lactose monohydrate; magnesium stearate; colloidal anhydrous silica; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350; lecithin
Oral
10
(S2) Pharmacy Medicine
Spasm of the gastrointestinal tract.
Visual Identification: Off white, round, biconvex, film coated tablet, plain on both sides; Container Type: Blister Pack; Container Material: PVC/PE/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert
Licence status A
2013-05-31